Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells

Tracy King, Lane Bushman, Jennifer Kiser, Peter L. Anderson, Michelle Ray, Thomas Delahunty, Courtney V Fletcher

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

To facilitate the evaluation of drug safety, virologic activity, and pharmacokinetics, an anion exchange isolation of tenofovir-diphosphate (TFV-DP) from human peripheral blood mononuclear cells (hPBMCs), coupled with dephosphorylation, desaltation, and detection by LC-MS-MS was validated. hPBMCs were harvested from whole blood, lysed, and a suspension of intracellular tenofovir moieties was produced. TFV-DP was isolated from TFV-monophosphate (TFV-MP) and tenofovir (TFV), dephosphorylated with acid phosphatase to form TFV and then desalted and concentrated, making it possible for tandem mass spectral detection. An LC-MS-MS methodology was developed and validated for the determination of TFV concentrations, which directly correspond with the intra-hPBMC TFV-DP concentration. The assay was linear in the range of 50-10,000 fmol per sample. The lower limit of quantitation (LLOQ) of the method is 10 fmol per million cells with 5 million hPBMCs used. This paper outlines the development and validation of the determination of TFV-DP concentrations in femtomoles per million hPBMCs.

Original languageEnglish (US)
Pages (from-to)147-156
Number of pages10
JournalJournal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
Volume843
Issue number2
DOIs
StatePublished - Nov 7 2006

Fingerprint

Tenofovir
Liquid chromatography
Liquid Chromatography
Blood Cells
Blood
Drug Evaluation
Acid Phosphatase
Pharmacokinetics
Anions
Suspensions
tenofovir diphosphate
Assays
Safety

Keywords

  • LC-MS-MS
  • Peripheral blood mononuclear cells
  • Tenofovir-diphosphate

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry
  • Clinical Biochemistry
  • Cell Biology

Cite this

Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells. / King, Tracy; Bushman, Lane; Kiser, Jennifer; Anderson, Peter L.; Ray, Michelle; Delahunty, Thomas; Fletcher, Courtney V.

In: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 843, No. 2, 07.11.2006, p. 147-156.

Research output: Contribution to journalArticle

@article{5be3c1aca76241c5a8abca9a8dd8aceb,
title = "Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells",
abstract = "To facilitate the evaluation of drug safety, virologic activity, and pharmacokinetics, an anion exchange isolation of tenofovir-diphosphate (TFV-DP) from human peripheral blood mononuclear cells (hPBMCs), coupled with dephosphorylation, desaltation, and detection by LC-MS-MS was validated. hPBMCs were harvested from whole blood, lysed, and a suspension of intracellular tenofovir moieties was produced. TFV-DP was isolated from TFV-monophosphate (TFV-MP) and tenofovir (TFV), dephosphorylated with acid phosphatase to form TFV and then desalted and concentrated, making it possible for tandem mass spectral detection. An LC-MS-MS methodology was developed and validated for the determination of TFV concentrations, which directly correspond with the intra-hPBMC TFV-DP concentration. The assay was linear in the range of 50-10,000 fmol per sample. The lower limit of quantitation (LLOQ) of the method is 10 fmol per million cells with 5 million hPBMCs used. This paper outlines the development and validation of the determination of TFV-DP concentrations in femtomoles per million hPBMCs.",
keywords = "LC-MS-MS, Peripheral blood mononuclear cells, Tenofovir-diphosphate",
author = "Tracy King and Lane Bushman and Jennifer Kiser and Anderson, {Peter L.} and Michelle Ray and Thomas Delahunty and Fletcher, {Courtney V}",
year = "2006",
month = "11",
day = "7",
doi = "10.1016/j.jchromb.2006.05.043",
language = "English (US)",
volume = "843",
pages = "147--156",
journal = "Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences",
issn = "1570-0232",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells

AU - King, Tracy

AU - Bushman, Lane

AU - Kiser, Jennifer

AU - Anderson, Peter L.

AU - Ray, Michelle

AU - Delahunty, Thomas

AU - Fletcher, Courtney V

PY - 2006/11/7

Y1 - 2006/11/7

N2 - To facilitate the evaluation of drug safety, virologic activity, and pharmacokinetics, an anion exchange isolation of tenofovir-diphosphate (TFV-DP) from human peripheral blood mononuclear cells (hPBMCs), coupled with dephosphorylation, desaltation, and detection by LC-MS-MS was validated. hPBMCs were harvested from whole blood, lysed, and a suspension of intracellular tenofovir moieties was produced. TFV-DP was isolated from TFV-monophosphate (TFV-MP) and tenofovir (TFV), dephosphorylated with acid phosphatase to form TFV and then desalted and concentrated, making it possible for tandem mass spectral detection. An LC-MS-MS methodology was developed and validated for the determination of TFV concentrations, which directly correspond with the intra-hPBMC TFV-DP concentration. The assay was linear in the range of 50-10,000 fmol per sample. The lower limit of quantitation (LLOQ) of the method is 10 fmol per million cells with 5 million hPBMCs used. This paper outlines the development and validation of the determination of TFV-DP concentrations in femtomoles per million hPBMCs.

AB - To facilitate the evaluation of drug safety, virologic activity, and pharmacokinetics, an anion exchange isolation of tenofovir-diphosphate (TFV-DP) from human peripheral blood mononuclear cells (hPBMCs), coupled with dephosphorylation, desaltation, and detection by LC-MS-MS was validated. hPBMCs were harvested from whole blood, lysed, and a suspension of intracellular tenofovir moieties was produced. TFV-DP was isolated from TFV-monophosphate (TFV-MP) and tenofovir (TFV), dephosphorylated with acid phosphatase to form TFV and then desalted and concentrated, making it possible for tandem mass spectral detection. An LC-MS-MS methodology was developed and validated for the determination of TFV concentrations, which directly correspond with the intra-hPBMC TFV-DP concentration. The assay was linear in the range of 50-10,000 fmol per sample. The lower limit of quantitation (LLOQ) of the method is 10 fmol per million cells with 5 million hPBMCs used. This paper outlines the development and validation of the determination of TFV-DP concentrations in femtomoles per million hPBMCs.

KW - LC-MS-MS

KW - Peripheral blood mononuclear cells

KW - Tenofovir-diphosphate

UR - http://www.scopus.com/inward/record.url?scp=33750344235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750344235&partnerID=8YFLogxK

U2 - 10.1016/j.jchromb.2006.05.043

DO - 10.1016/j.jchromb.2006.05.043

M3 - Article

VL - 843

SP - 147

EP - 156

JO - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

JF - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

SN - 1570-0232

IS - 2

ER -